Intestinal polyp inhibitor

Details for Australian Patent Application No. 2005293000 (hide)

Owner Otsuka Pharmaceutical Factory, Inc. Japan as Represented by Director General of Agency of National Cancer Center

Inventors Wakabayashi, Keiji; Mutoh, Michihiro

Agent Freehills

Pub. Number AU-B-2005293000

PCT Pub. Number WO2006/040940

Priority 2004-299217 13.10.04 JP

Filing date 30 September 2005

Wipo publication date 20 April 2006

Acceptance publication date 20 January 2011

International Classifications

A61K 31/662 (1970.01) - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/040940 Priority application(s): WO2006/040940

20 January 2011 Application Accepted

  Published as AU-B-2005293000

19 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005293038-Metal producing method and producing device by molten salt electrolysis

2005292984-Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio )-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same